Cellesce Overview
- Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.78M
Cellesce General Information
Description
Operator of a biochemical engineering company intended to develop organoids. The company bioprocessing technology, and specializes in the development, scale-up, and manufacture of patient-derived organoids and uses its proprietary bioprocess and bioreactors for the expansion of human-derived normal and cancer PDOs for multiple applications, including drug screening, enabling healthcare professionals to utilize in-line sensors and real-time monitoring to ensure precise culture conditions, improved yield, and control of organoid size and reduced batch to batch, user to user variability and use them in drug efficacy testing.
Contact Information
Website
www.cellesce.com
Formerly Known As
BBF Bio
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- Cardiff Medicentre
- Heath Park
- Cardiff CF14 4UJ
- Wales, United Kingdom
+44 029 0000 0000
Cellesce Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 01-Jan-2021 | $1.78M | Completed | Generating Revenue | ||
| 6. Grant | 01-Jun-2020 | 00000 | Completed | Generating Revenue | ||
| 5. Merger/Acquisition | 06-Dec-2022 | 0000 | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Jan-2020 | 00.000 | 0000 | Completed | Generating Revenue | |
| 3. Later Stage VC | 01-Jun-2019 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 2. Later Stage VC | 23-Mar-2018 | $900K | $1.04M | 00.000 | Completed | Generating Revenue |
| 1. Seed Round | 12-Nov-2015 | $140K | $140K | 00000 | Completed | Startup |
Cellesce Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| Ordinary | 000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 |
Cellesce Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a biochemical engineering company intended to develop organoids. The company bioprocessing technology, and s
Drug Discovery
Cardiff, United Kingdom
21
As of 2022
0000
0000000000
000000
piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000 000000000
Cambridge, United Kingdom
00
As of 0000
000.00
0000000000 0
000.00
Add Comparison
Cellesce Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 0000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
Cellesce Patents
Cellesce Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202107891-D0 | Apparatus | Inactive | 02-Jun-2021 | ||
| GB-201902415-D0 | A device | Inactive | 22-Feb-2019 | ||
| GB-201611982-D0 | Cell culture | Inactive | 11-Jul-2016 | 0000000000 | |
| US-20190249137-A1 | Methods for culturing organoids | Active | 11-Jul-2016 | 0000000000 | |
| US-20220333064-A1 | Methods for culturing organoids | Pending | 11-Jul-2016 | C12N5/0081 |
Cellesce Executive Team (8)
Cellesce Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christopher Thompson | Self | Board Member | 000 0000 |
| Francis Bealin-Kelly | Cellesce | Co-Chief Operating Officer, Chairman of Scientific Advisory Board & Board Member | 000 0000 |
| John Allbrook | Self | Chairman | 000 0000 |
| Julian Chaudhuri | Cellesce | Co-Founder & Scientific Advisory Board Member | 000 0000 |
| Kathryn Rowley Ph.D | Self | Board Member | 000 0000 |
Cellesce Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cellesce Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Development Bank of Wales | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Innovate UK | Government | Minority | 000 0000 | 000000 0 | |
| NC3Rs | Government | Minority | 000 0000 | 000000 0 | |
| NG Bio (UK) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Tangram Partners (Godalming) | Venture Capital | Minority | 000 0000 | 000000 0 |